Concepedia

Publication | Closed Access

AGS16F Is a Novel Antibody Drug Conjugate Directed against ENPP3 for the Treatment of Renal Cell Carcinoma

DOI

46

Citations

24

References

2015

Year

Fernando Doñate, Arthur Raitano, Kendall Morrison, Zili An, Linnette Capo, Héctor Aviña, Sher Karki, Karen Morrison, Peng Yang, Jimmy Ou,
Clinical Cancer Research

Abstract

AGS16F is a promising new therapeutic option for patients with RCC and is currently being evaluated in a phase I clinical trial.

References

YearCitations

Page 1